Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Martin H. Markowitz
Aaron Diamond Aids Research Center, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Gilead
Payment for services (e.g., consulting fees, honoraria, paid authorship)
The Principal Investigator receives financial compensation exceeding $5,000 USD from Gilead Sciences for services as a consultant and for speaking on unbranded topics related to HIV. As Gilead Sciences has provided ledipasvir/sofosbuvir (Harvoni) to the study for the treatment of HCV monoinfected individuals, this represents a financial conflict of interest for which a management plan has been instituted.
Correlates and Consequences of Increased Immune Activation in HIV + and - IDUs
In response to RFA-DA-12-009, 'Systems Biology Approaches in HIV/AIDS and Substance Use' our multidisciplinary team will use a multifaceted approach incorporating transcriptional profiling and analyses to better understand the intersection of non-sterile injection drug injection, direct effect of opiates, and infection with CV on immune activation in blood and tissue. We will explore the consequences of increased immune activation on immune reconstitution in blood and tissue during combination antiretroviral therapy using a novel systems biology approach. The intersection of IDU, HIV-1, and HCV remains an important public health issue that requires intense investigation to identify novel therapeutic targets; the results of this project have the potential and to affect the clinica management of HIV-related disease and to improve outcomes in affected individuals.
Filed on March 17, 2015.
Tell us what you know about Martin H. Markowitz's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.